ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of its supplemental Biologics License ...
Donald Trump in the Oval Office of the White House. Lucas Parker/Shutterstock President Donald Trump's administration has ordered US diplomats to lobby against attempts to regulate US tech companies' ...
The ministry of home affairs (MHA) on Monday released India’s first comprehensive national counterterrorism policy and strategy titled Prahaar, aiming to deal with all terrorist acts and denying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results